DOI:
10.1055/s-00000093
Ernährung & Medizin
LinksClose Window
References
Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S.
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Lancet 2005; 365: 1389-1397
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.